Speaking Engagements5.14.25
IP Strategy Summit: Biotech & Pharma
Ron Cahill and Allen Baum will discuss IP strategies in the evolving biopharma landscape.
Ron Cahill, partner and chair of Barnes & Thornburg’s Life Sciences practice group, and partner Allen Baum will speak at the upcoming IP Strategy Summit: Biotech & Pharma on May 14. The summit brings together leading IP professionals and in-house counsel to explore practical strategies for protecting and maximizing IP in a rapidly evolving biopharma environment.
Whether a patent has been properly listed in the Orange Book is emerging as a hotly contested issue in counterclaims, antitrust suits and FTC investigations. In this session, Ron Cahill will explore the evolving legal landscape around Orange Book listability, recent case law, and what it could mean for your next Hatch-Waxman case.
Keep Up to Date in a Changing World
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
